Where traditional Chinese medicine meets Western medicine in the prevention of rheumatoid arthritis

• Published in: Journal of internal medicine Vol. 292; no. 5; pp. 745 - 763
• Main Authors: Jakobsson, Per‐Johan, Robertson, Luke, Welzel, Janika, Zhang, Mingshu, Zhihua, Yang, Kaixin, Gao, Runyue, Huang, Zehuai, Wen, Korotkova, Marina, Göransson, Ulf
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.11.2022
• Subjects: Alleles; Antibodies; Arthritis; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - prevention & control; Autoantibodies; Chinese medicine; Citrulline; Clinical trials; Clinical Trials as Topic; Drb1 protein; Drugs, Chinese Herbal - therapeutic use; Epitopes; Epitopes - genetics; Genetic Predisposition to Disease; Herbal medicine; Histocompatibility antigen HLA; HLA-DRB1 Chains - genetics; Humans; inflammation; Joint diseases; Medicin och hälsovetenskap; Medicinal plants; Medicine, Chinese Traditional; Peptides; Prevention; Proteins; Rheumatoid arthritis; Rheumatoid factor; Rheumatoid Factor - genetics; Tea; Traditional Chinese medicine; inflammation; traditional Chinese medicine; rheumatoid arthritis
• ISSN: 0954-6820; 1365-2796; 1365-2796
• DOI: 10.1111/joim.13537

Chinese medicine has a long tradition of use against rheumatoid arthritis (RA). The formulations are based on combinations of typically 5–10 plants, which are usually boiled and administered as a decoction or tea. There are few clinical trials performed so the clinical evidence is sparse. One fundamental of traditional medicine is to prevent disease. RA is an autoimmune, inflammatory and chronic disease that primarily affects the joints of 0.5%–1% of the population. In two out of three of the cases, the patients are characterised by the presence of autoantibodies such as the rheumatoid factor and the more disease‐specific autoantibody against citrullinated proteins, so‐called ‘ACPA’ (anticitrullinated protein/peptide antibodies). ACPA positivity is also strongly associated with specific variations in the HLA‐DRB1 gene, the shared epitope alleles. Together with smoking, these factors account for the major risks of developing RA. In this review, we will summarise the background using certain plant‐based formulations based on Chinese traditional medicine for the treatment and prevention of RA and the strategy we have taken to explore the mechanisms of action. We also summarise the major pathophysiological pathways related to RA and how these could be analysed. Finally, we summarise our ideas on how a clinical trial using Chinese herbal medicine to prevent RA could be conducted.